2024 Q2 Form 10-Q Financial Statement

#000192956124000082 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $930.0M $913.0M $1.010B
YoY Change -3.43% -9.6% -23.02%
Cost Of Revenue $750.0M $752.0M $820.0M
YoY Change -4.09% -8.29% -23.79%
Gross Profit $180.0M $161.0M $190.0M
YoY Change -0.55% -15.26% -19.49%
Gross Profit Margin 19.35% 17.63% 18.81%
Selling, General & Admin $154.0M $145.0M $153.0M
YoY Change 6.94% -5.23% -4.97%
% of Gross Profit 85.56% 90.06% 80.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.00M $16.00M $18.00M
YoY Change -5.56% -11.11% -14.29%
% of Gross Profit 9.44% 9.94% 9.47%
Operating Expenses $154.0M $161.0M $153.0M
YoY Change -4.94% 5.23% -15.93%
Operating Profit $0.00 $0.00 $5.000M
YoY Change -100.0% -100.0% -90.74%
Interest Expense -$8.000M -$8.000M -$8.000M
YoY Change 0.0% 0.0%
% of Operating Profit -160.0%
Other Income/Expense, Net $0.00 -$1.000M
YoY Change
Pretax Income -$8.000M -$21.00M -$3.000M
YoY Change -233.33% 600.0% -105.88%
Income Tax -$1.000M -$6.000M -$3.000M
% Of Pretax Income
Net Earnings -$7.000M -$15.00M $0.00
YoY Change -333.33% -100.0%
Net Earnings / Revenue -0.75% -1.64% 0.0%
Basic Earnings Per Share -$0.06 -$0.13 $0.00
Diluted Earnings Per Share -$0.06 -$0.13 $0.00
COMMON SHARES
Basic Shares Outstanding 117.5M shares 117.1M shares 116.6M shares
Diluted Shares Outstanding 117.6M shares 117.2M shares 119.4M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.000M $7.000M $121.0M
YoY Change -94.35% -94.21% 163.04%
Cash & Equivalents $7.000M $7.000M $121.0M
Short-Term Investments
Other Short-Term Assets $44.00M $47.00M $46.00M
YoY Change -10.2% 2.17% 9.52%
Inventory
Prepaid Expenses
Receivables $725.0M $716.0M $862.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $776.0M $770.0M $1.029B
YoY Change -15.28% -25.17% -21.21%
LONG-TERM ASSETS
Property, Plant & Equipment $328.0M $321.0M $269.0M
YoY Change 17.14% 19.33% 8.47%
Goodwill $630.0M $630.0M $630.0M
YoY Change 0.0% 0.0%
Intangibles $62.00M $65.00M $76.00M
YoY Change -15.07% -14.47%
Long-Term Investments
YoY Change
Other Assets $17.00M $13.00M $14.00M
YoY Change 30.77% -7.14% -17.65%
Total Long-Term Assets $1.037B $1.029B $989.0M
YoY Change 4.12% 4.04% -0.1%
TOTAL ASSETS
Total Short-Term Assets $776.0M $770.0M $1.029B
Total Long-Term Assets $1.037B $1.029B $989.0M
Total Assets $1.813B $1.799B $2.018B
YoY Change -5.18% -10.85% -12.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $382.0M $372.0M $496.0M
YoY Change -11.57% -25.0% -32.43%
Accrued Expenses $197.0M $274.0M $265.0M
YoY Change -23.64% 3.4% -18.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $16.00M $16.00M $4.000M
YoY Change 300.0% 300.0%
Total Short-Term Liabilities $662.0M $674.0M $820.0M
YoY Change -5.29% -17.8% -22.86%
LONG-TERM LIABILITIES
Long-Term Debt $370.0M $351.0M $451.0M
YoY Change -17.96% -22.17%
Other Long-Term Liabilities $42.00M $191.0M $37.00M
YoY Change -73.08% 416.22% -73.19%
Total Long-Term Liabilities $572.0M $542.0M $613.0M
YoY Change -5.77% -11.58% 344.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $662.0M $674.0M $820.0M
Total Long-Term Liabilities $572.0M $542.0M $613.0M
Total Liabilities $1.234B $1.217B $1.433B
YoY Change -6.73% -15.07% 14.37%
SHAREHOLDERS EQUITY
Retained Earnings -$16.00M -$9.000M $2.000M
YoY Change -420.0% -550.0%
Common Stock $1.000M $1.000M $1.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $579.0M $582.0M $585.0M
YoY Change
Total Liabilities & Shareholders Equity $1.813B $1.799B $2.018B
YoY Change -5.18% -10.85% -12.11%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$7.000M -$15.00M $0.00
YoY Change -333.33% -100.0%
Depreciation, Depletion And Amortization $17.00M $16.00M $18.00M
YoY Change -5.56% -11.11% -14.29%
Cash From Operating Activities -$5.000M $7.000M $42.00M
YoY Change -120.83% -83.33% -59.22%
INVESTING ACTIVITIES
Capital Expenditures $11.00M $11.00M $12.00M
YoY Change -31.25% -8.33% 0.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$11.00M -$11.00M -$12.00M
YoY Change -31.25% -8.33% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.00M 6.000M -$8.000M
YoY Change -420.0% -175.0% -89.19%
NET CHANGE
Cash From Operating Activities -5.000M 7.000M $42.00M
Cash From Investing Activities -11.00M -11.00M -$12.00M
Cash From Financing Activities 16.00M 6.000M -$8.000M
Net Change In Cash 0.000 2.000M $23.00M
YoY Change -100.0% -91.3% 35.29%
FREE CASH FLOW
Cash From Operating Activities -$5.000M $7.000M $42.00M
Capital Expenditures $11.00M $11.00M $12.00M
Free Cash Flow -$16.00M -$4.000M $30.00M
YoY Change -300.0% -113.33% -67.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117544000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
117544000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
699000000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
759000000 usd
CY2024Q1 rxo Direct Operating Expense Excluding Depreciation Depletion And Amortization
DirectOperatingExpenseExcludingDepreciationDepletionAndAmortization
53000000 usd
CY2023Q1 rxo Direct Operating Expense Excluding Depreciation Depletion And Amortization
DirectOperatingExpenseExcludingDepreciationDepletionAndAmortization
61000000 usd
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153000000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18000000 usd
CY2024Q1 rxo Transaction And Integration Costs
TransactionAndIntegrationCosts
1000000 usd
CY2023Q1 rxo Transaction And Integration Costs
TransactionAndIntegrationCosts
6000000 usd
CY2024Q1 us-gaap Restructuring Costs
RestructuringCosts
11000000 usd
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
8000000 usd
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
39000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5000000 usd
CY2024Q1 us-gaap Other Income
OtherIncome
1000000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
0 usd
CY2024Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8000000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117217000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116600000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117217000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119369000 shares
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18000000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5000000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-7000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2000000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-27000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-40000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-41000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-9000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
21000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12000000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
CY2024Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
31000000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2000000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
23000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
98000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
23000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10000000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
6000000 usd
CY2024Q1 rxo Cash Paid For Interest
CashPaidForInterest
1000000 usd
CY2023Q1 rxo Cash Paid For Interest
CashPaidForInterest
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
594000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-15000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
5000000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
518000 shares
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
582000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
587000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
5000000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
453000 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
585000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 reportingsegment
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
913000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
913000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1010000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
61000000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
6000000 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
11000000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
5000000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
12000000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
375000000 usd
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
367000000 usd
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
367000000 usd
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
359000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
16000000 usd
CY2024Q1 us-gaap Debt Current
DebtCurrent
16000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
3000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
3000000 usd
CY2024Q1 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
359000000 usd
CY2024Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
351000000 usd
CY2023Q4 rxo Debt Instrument Face Amount Non Current
DebtInstrumentFaceAmountNonCurrent
364000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
356000000 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
8000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-15000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
0 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
117217000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116600000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2769000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
117217000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119369000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2514 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
925 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001929561-24-000082-index-headers.html Edgar Link pending
0001929561-24-000082-index.html Edgar Link pending
0001929561-24-000082.txt Edgar Link pending
0001929561-24-000082-xbrl.zip Edgar Link pending
exhibit1019-rxo2024psugr.htm Edgar Link pending
exhibit1019-rxo2024psugr001.jpg Edgar Link pending
exhibit1019-rxo2024psugr002.jpg Edgar Link pending
exhibit1019-rxo2024psugr003.jpg Edgar Link pending
exhibit1019-rxo2024psugr004.jpg Edgar Link pending
exhibit1019-rxo2024psugr005.jpg Edgar Link pending
exhibit1019-rxo2024psugr006.jpg Edgar Link pending
exhibit1019-rxo2024psugr007.jpg Edgar Link pending
exhibit1019-rxo2024psugr008.jpg Edgar Link pending
exhibit1019-rxo2024psugr009.jpg Edgar Link pending
exhibit1019-rxo2024psugr010.jpg Edgar Link pending
exhibit1019-rxo2024psugr011.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rxo-20240331.htm Edgar Link pending
rxo-20240331.xsd Edgar Link pending
rxo-20240331_g1.jpg Edgar Link pending
rxo2024q110-qexx311.htm Edgar Link pending
rxo2024q110-qexx312.htm Edgar Link pending
rxo2024q110-qexx321.htm Edgar Link pending
rxo2024q110-qexx322.htm Edgar Link pending
Show.js Edgar Link pending
rxo-20240331_cal.xml Edgar Link unprocessable
rxo-20240331_def.xml Edgar Link unprocessable
rxo-20240331_lab.xml Edgar Link unprocessable
rxo-20240331_pre.xml Edgar Link unprocessable
rxo-20240331_htm.xml Edgar Link completed